Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms

MT Newswires05-12

Trendlines Group (SGX:42T) said its board approved a capital injection into portfolio companies Ceretrieve and Vensica Medical by controlling shareholder Librae Holdings.

Shares of the agrifood and med-tech company were down over 1% in Tuesday's afternoon trade.

Librae will invest around $850,000 in the units. Additionally, Trendlines will infuse a total of $550,000 to the portfolio firms, according to a Monday filing with the Singapore Exchange.

The funding is aimed at supporting the ongoing operations of the portfolio companies and helping them achieve successful exits, the filing said.

Ceretrieve develops neurointerventional devices, while Vensica Medical specializes in bladder-targeted therapies.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment